Home - Clinical Trials Arena
WEBModerna blamed after children offered £1,500 to take part in Covid-19 trial. Under the EU Clinical Trials Regulation, financial incentives are not allowed for participants under 16 to prevent undue influence. More themes. Artificial Intelligence. Cloud.
Gilead’s lenacapavir: HIV prospects strongest in long-acting …
WEBAug 25, 2021 · Gilead’s lenacapavir will find its strongest niche as a long-acting HIV combination treatment, experts said. Gilead announced a collaboration with Merck in March to study lenacapavir with islatravir, a nucleoside reverse transcriptase translocation inhibitor (NRTTI), which is also a new drug class in HIV.
Ozempic (semaglutide) for the Treatment of Type 2 Diabetes
WEBOzempic® (semaglutide) is a glucagon-like peptide (GLP-1) receptor agonist indicated for the treatment of Type 2 diabetes in adults.
Mounjaro (tirzepatide) for the Treatment of Type 2 Diabetes, USA
WEBJun 19, 2024 · Mounjaro (tirzepatide) injection is a new dual-targeted therapy indicated for the management of type 2 diabetes in adults.
News - Clinical Trials Arena
WEBBiomea’s stock bounces back as FDA lifts clinical hold on diabetes trials. Biomea Fusion’s stock is on the up after the company plans to resume two clinical trials evaluating its type 1…. Phalguni Deswal. News.
Obesity: Six trials to watch over the next 12 months
WEBJun 30, 2023 · With an estimated market value of $37.1bn in 2031, the race for the development of obesity medications is on. Here are some trials to watch.
Top Ongoing mRNA Herpes Vaccine Trials - Clinical Trials Arena
WEBFeb 2, 2023 · Stay updated on the latest mRNA vaccine trials shaping the future of immunization. Explore promising developments and potential breakthroughs.
Hidradenitis Suppurativa Ripe for competition with Humira
WEBJul 29, 2021 · Cosentyx vs Humira: Hidradenitis Suppurativa and Current Treatments Need to know: Analysts forecast that the global hidradenitis suppurativa market may garner sales of $763.6m in 2021, with a compound annual growth rate of 4.2% up to 2023 Moderate-to-severe patients have varying efficacy milage with Humira, underscoring the need for more biologic options Candidates Cosentyx and bimekizumab are ...
First patient dosed in BioNTech Phase II trial of mRNA cancer vaccine
WEBJun 18, 2021 · The BioNTech BNT111-01 trial, which is being carried out in collaboration with Regeneron, has dosed the first patient in Europe. The first patient has been treated in a Phase II cancer vaccine trial by BioNTech, evaluating its mRNA-based therapy BNT111 in combination with Libtayo (cemiplimab) in patients with anti-PD1-refractory/relapsed ...
Lyrica (Pregabalin) for the Treatment of Neuropathic Pain, USA
WEBLyrica (pregabalin) is an anti-epileptic drug indicated for the treatment of neuropathic pain associated with diabetic peripheral neuropathy (DPN).
- Some results have been removed